DR
Dr. Robert Redfield, M.D.
Former Director of CDC (External Collaborator/Interview Subject)
Turn TherapeuticsTherapeutic Areas
Turn Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GX-03 | Eczema (Atopic Dermatitis) | Phase 1 |
| Unnamed Onychomycosis Program | Onychomycosis | Late-stage clinical |
| Hexagen™ Wound Dressing | Wound Care | Approved/FDA-cleared |
| Thermostable Vaccine Delivery | Infectious Disease (Global Health) | Not specified |